文摘
Inhibition of amyloid 尾-protein (A尾)-induced toxicity is a promising therapeutic strategy for Alzheimer鈥檚 disease (AD). Previously, we reported that the C-terminal tetrapeptide A尾(39鈥?2) is a potent inhibitor of neurotoxicity caused by A尾42, the form of A尾 most closely associated with AD. Here, initial structure鈥揳ctivity relationship studies identified key structural requirements, including chirality, side-chain structure, and a free N-terminus, which control A尾(39鈥?2) inhibitory activity. To elucidate the binding site(s) of A尾(39鈥?2) on A尾42, we used intrinsic tyrosine (Y) fluorescence and solution-state NMR. The data suggest that A尾(39鈥?2) binds at several sites, of which the predominant one is located in the N-terminus of A尾42, in agreement with recent modeling predictions. Thus, despite the small size of A尾(39鈥?2) and the hydrophobic, aliphatic nature of all four side-chains, the interaction of A尾(39鈥?2) with A尾42 is controlled by specific intermolecular contacts requiring a combination of hydrophobic and electrostatic interactions and a particular stereochemistry.